Recombinant, Human, aa23-226, His-Tag (SLAM family member 7, CD2 subset 1, CD2-like Receptor-activating cytotoxic cells, CRACC, CS1, CD319)
Catalog No : USB-351477
508.06€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Recombinant, Human, aa23-226, His-Tag (SLAM family member 7, CD2 subset 1, CD2-like Receptor-activating cytotoxic cells, CRACC, CS1, CD319) | ||
|---|---|---|---|
| Catalog No | USB-351477 | ||
| Supplier’s Catalog No | 351477 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, human from insect cell line | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 23.4 | ||
| Storage | -20°C/-70°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | ~95% (SDS-PAGE) | ||
| Form | Supplied as a liquid in PBS, pH 7.4, 10% glycerol. | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | ~95% (SDS-PAGE) | ||
| Description | SLAMF7, also known as SLAM family member 7, is a single-pass type 1 membrane protein and a member of the CS2 family of cell surface receptors. Isoform 1 of this protein mediates NK cell activation through a SH2D1A-independent extracellular signal-regulated ERK-mediated pathway. It may play a role in lymphocyte adhesion. SLAMF7 can exert activating of inhibitory influences on cells of the immune system depending on cellular context and the availability of effector proteins. Source: Recombinant protein corresponding to aa23-226 from human SLAMF7, fused to His-tag at C-terminal expressed in insect cell. Molecular Weight: ~23.4kD (212aa) AA Sequence: SGPVKELVGS VGGAVTFPLK SKVKQVDSIV WTFNTTPLVT IQPEGGTIIV TQNRNRERVD FPDGGYSLKL SKLKKNDSGI YYVGIYSSSL QQPSTQEYVL HVYEHLSKPK VTMGLQSNKN GTCVTNLTCC MEHGEEDVIY TWKALGQAAN ESHNGSILPI SWRWGESDMT FICVARNPVS RNFSSPILAR KLCEGAADDP DSSMLEHHHH HH Endotoxin: ~1EU/1ug (LAL) Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
© 2020 Imugex All Rights Reserved